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ABSTRACT
The tight regulation of transiently expressed
antimicrobial peptides (AMPs) with a distinct
antimicrobial spectrum and different expression
kinetics contributes greatly to the properly
regulated immune response for resistance to
pathogens and for the maintenance of mutualistic
microbiota in Drosophila. The important role of dif-
ferential regulation of AMP expression at the
posttranscriptional level needs to be elucidated. It
was observed that the highly expressed Cecropin A1
(CecA1) mRNA encoding a broad antimicrobial
spectrum AMP against both bacteria and fungi
decayed more quickly than did the moderately
expressed Diptericin mRNA encoding AMP against
Gram negative bacteria. The mRNA stability of
AMPs is differentially regulated and is attributed to
the specific interaction between cis-acting ARE in
30-UTR of AMP mRNA and the RNA destabilizing
protein transactor Tis11 as shown in co-immuno-
precipitation of the Tis11 RNP complex with CecA1
mRNA but not other AMP mRNA. The p38MAPK
was further demonstrated to play a crucial role
in stabilizing ARE-bearing mRNAs by inhibiting
Tis11-mediated degradation in LPS induced AMP
expression. This evidence suggests an evolu-
tionarily conserved and functionally important
molecular basis for and effective approach to
exact control of AMP gene expression. These
mechanisms thereby orchestrate a well balanced
and dynamic antimicrobial spectrum of innate
immunity to resist infection and maintain resident
microbiota properly.
INTRODUCTION
The innate immune system is critical for the host not only
to control microbial infection at the front line of immune
defense, but also to maintain the mutualistic relationship
with the resident microbiota community, which is of great
importance for supporting and sustaining health. An
essential aspect of the Drosophila melanogaster immune
response, which is equivalent to innate immunity in
mammals, is the spatially and temporally regulated
expression of a battery of antimicrobial peptides (AMPs)
(1–5). The AMPs have diﬀerent spectra of activity, target-
ing diﬀerent classes of pathogenic microorganisms (1–3).
Diptericin (Dpt), Drosocin (Dro) and Attacin (Att) act
against Gram-negative bacteria. Defensin (Def) is active
against Gram-positive bacteria, whereas Drosomycin
(Drs) and Metchnikowin (Mtk) are antifungal agents.
Cecropin A1 (CecA1) has a broad antibacterial spectrum
against both bacteria and fungi (6,7). Each AMP works in
concert with others to take eﬀect with an integrated and
proper antimicrobial scope. Because of the distinct anti-
bacterial spectrum of each AMP, the tight regulation of
extent and duration of individual AMP expression
contributes greatly to the overall eﬀect on the resistance
to pathogens and the maintenance of the resident
microbiota (8,9). Therefore, it is important to elucidate
the diﬀerentially regulated gene expression of AMPs
with distinct kinetics and antimicrobial spectra at
multiple levels. Such an understanding would lead to
the revelation of its crucial role in the orchestration of
eﬀective and eﬃcient antimicrobial spectra by precise
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host immune responses.
Although AMPs are constitutively synthesized in
speciﬁc tissues at a basal level (3), a characteristic aspect
of AMP synthesis in D. melanogaster is the transient
expression of a battery of antimicrobial peptides upon
immune response, which is critical for protection against
many microbial pathogens (1–3,10,11). Prior to infection,
most AMP mRNA levels are very low, but transcripts
accumulate rapidly after infection (3,5,12). From then
on, AMP mRNA levels decrease (3,12). Certainly, the
transient expression of AMP genes is tightly regulated so
that insects can response to antigen quickly to resist the
predation of rapidly dividing pathogenic microorganisms,
and then withdraw highly active AMPs successively to
avoid prolonged inhibition of mutualistic microbiota in
the host (8–11). This delicate regulation depends upon
the interplay among elements that control gene expression
at multiple levels such as transcription, mRNA stability
and translation (13).
Undoubtedly, transcriptional control at kB-like sites
bound by Rel family proteins (14–18) is a determinant
of the distinct spectra and of the stereotypical kinetics of
AMP gene expression activated by diﬀerent microbes
through Toll and IMD pathways (3,5,11,19). In fact,
in addition to transcription, posttranscriptional events,
particularly the stability of speciﬁc mRNA, are also
important determinants of the extent and duration of
gene expression (12,20–23). After analysis of sequence
motifs in Drosophila AMPs, it was observed that the
mRNA 30-UTR of quite a few AMPs contain AU-rich
sequences similar to the adenylate and uridylate rich
element (AU-rich element, ARE). This is a highly
conserved posttranscriptional regulatory element found
throughout evolution from yeasts and insects to
mammals (24–26). In mammalian cells, ARE controls
mRNA stability via interactions with speciﬁc RNA
binding proteins: some ARE-binding proteins (AUBPs)
target the transcript for degradation, such as tristetra-
prolin (TTP), whereas others, such as HuR, mediate tran-
script stabilization (20,26–29). In addition, it has been
implied that AREs can exert either a stabilizing or
destabilizing eﬀect on mRNA depending upon the p38
mitogen-activated protein kinase (p38MAPK) activity
within the mammalian cells (30,31). In general, the ARE
sequences speciﬁcally bound by AUBPs include a central
AU3-5A core with a UU contributed from the AU3-5Ao n
either side and are always found in the 30-UTR of a variety
of immediate response genes, including those encoding
cytokines, inﬂammatory mediators and other such
molecules (25,26,28,32,33). In light of the presence of
ARE motifs in the 30-UTR of AMP mRNA, one may
speculate that the transient expression of AMPs may be
under tight regulation at the posttranscriptional level,
particularly with regard to transcript stability control.
Thus, it is important to explore the fundamental aspects
of and relevant approaches to mRNA stability regulation
that control AMP expression diﬀerentially, and that could
ultimately translate the distinct expression kinetics of each
AMP gene into a dynamic and delicately orchestrated
antimicrobial spectrum combining each AMP’s intensity,
duration and speciﬁc activity.
In this study, posttranscriptional analyses of gene
expression of representative AMPs including CecA1 and
Dpt, which have similar but not identical ARE sequences
located in the 30-UTR, were performed to elucidate the
diﬀerential regulation of mRNA stability in AMP gene
expression and the crucial role of p38MAPK in stabilizing
ARE-bearing mRNAs by inhibiting Tis11-mediated deg-
radation in LPS induced AMP expression in Drosophila
macrophage-like S2* cells.
MATERIALS AND METHODS
Reagents
Escherichia coli Lipopolysaccharides (LPS) (62326),
SB203580 and 20-hydroxy-ecdysone (H5142) were
obtained from Sigma-Aldrich. Actinomycin D (Act.D)
was purchased from Ameresco, His-tag antibody from
Abmart. The gene-speciﬁc primers were synthesized by
Invitrogen China.
Cell culture
Drosophila Schneider (S2*) cells (kindly provided by
Dr Ge Baoxue) were cultured in 1 Schneider’s
Drosophila medium (Invitrogen) supplemented with 10%
FBS (Invitrogen), 50U/ml penicillin and 50ng/ml strepto-
mycin at 25 C (34). For the treatment with LPS in which
peptidoglycan (PGN) was the immune activator with the
ability to activate the IMD pathway (35,36), S2* cells were
incubated with 1mM 20-hydroxy-ecdysone to induce dif-
ferentiation for at least 24h prior to stimulation with
10mg/ml LPS. For p38MAPK inhibition, cells were
incubated with 10mM SB203580 or with vehicle (1%
dimethyl sulfoxide, DMSO) for 30min prior to
stimulation.
Plasmid constructs
The ﬁreﬂy luciferase (Fluc) gene and polyA signal of SV40
from pGL-3 Basic (Promega) was sub-cloned into
pAc5.1-Flag-V5-His C vector with Kpn† and Sal† to con-
struct pAC-Fluc plasmid. Using the S2* cells cDNA as
templates, the 30-UTR of Dpt (147bp), heat shock
protein 70 (HSP70) (234bp) and ribosomal protein 49
(rp49) (162bp), and fragments of I (full length of CecA1
30-UTR, 97bp), II (70bp), III (55bp), IV (42bp), V
(19bp) of CecA1 30-UTR were synthesized by PCR with
speciﬁc primers (Supplementary Table S1). The 30-UTR of
TNF-  was PCR ampliﬁed using THP1 cells cDNA as
templates. Excised with Xba† or Nhe† and puriﬁed with
a Gel Extract kit (Omega). DNA fragments were ligated
into the unique Xba† site of the pAC-Fluc, located down-
stream of the Fluc coding sequence. The renilla luciferase
(Rluc) gene from pRL-SV40 (Promega) was ligated
into Nhe†-Xba† sites of pAC-Fluc to replaced Fluc for
pAC-Rluc plasmid construction. The coding region of
Drosophila Tis11 was PCR ampliﬁed and sub-cloned
into pAc5.1-Flag-V5-His C vector with the Kpn† and
Not† sites residing downstream of actin5C promoter and
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coding region of human TTP from pCDNA3.0-myc-
TTP plasmid was sub-cloned into pAc5.1-Flag-V5-His C
plasmid with HindX and Not† to construct pAC-TTP
plasmid. All DNA constructs were veriﬁed by DNA
sequencing (Invitrogen, Shanghai, China).
RNA isolation and analysis of gene expression
Total RNA was isolated from S2* cells using Trizol
reagent (Invitrogen) and treated with DNase (Promega).
Total RNA (1mg) was used together with MMLV reverse
transcriptase (Promega) and oligo (dT)18 primer to syn-
thesize ﬁrst strand cDNA, which was used as a template
for quantitative real time RT–PCR (qRT–PCR) with
gene-speciﬁc primer pairs (Supplementary Table S2) and
SYBR Green PCR master mix (Toyobo) on an ABI
PRISM 7900 Fast Real Time PCR System (Applied
Biosystems). The expression level of CecA1 or Dpt was
normalized to rp49 and Fluc was normalized to Rluc in
each sample in order to quantify the relative levels of a
given mRNA according to the Ct analysis. For absolute
quantitative real time RT–PCR, the DNA standard
samples for AMPs and rp49 were made by PCR ampliﬁ-
cation and quantiﬁed using a spectrophotometer
(Beckman DU800). Absolute quantitative real time RT–
PCR was performed using serially diluted standard
samples as templates to make a standard ampliﬁcation
curve.
Act.D chase studies for mRNA stability measurement
For mRNA stability assays, S2* cells were incubated with
10mg/ml Act.D to inhibit transcription. At the indicated
time points after the addition of Act.D, cells were har-
vested and total RNA was extracted. The expression
levels of CecA1, Dpt and Fluc at each time point were
measured by qRT–PCR as described earlier and
normalized to the according rp49 levels. The remaining
mRNA was determined by comparison with the expres-
sion level of the relevant gene at the zero time point
(designated 100%) when Act.D was added.
Cell transfection and luciferase reporter assay
S2* cells were seeded at a density of 1 10
6cells/ml in
6-well plates. The next day, 0.5mg Fluc reporter plasmids
containing the indicated fragment from 30-UTR of various
genes and 0.5mg Rluc reporter plasmids (pAC-Rluc) were
co-transfected into cells using the calcium phosphate
precipitation method (Invitrogen). Three days after
transfection, cells were harvested and luciferase activities
were measured according to the recommended procedures
for the dual luciferase assay system (Promega) on a
PerkinElmer Lumat LB 9507 luminometer. The Fluc
activity was normalized to the activity of Rluc.
RNA interference
The primer sequences (Supplementary Table S3) used to
generate templates for synthesizing double-strand RNA
(dsRNA) of Tis11 and EGFP included a 50 T7 RNA
polymerase-binding site. For Tis11 dsRNA template
ampliﬁcation, S2* cells cDNA was used as template
in RT–PCR, while pEGFP-C1 vector (Clontech) was
used as template to amplify EGFP dsRNA template.
The puriﬁed PCR products were used as templates to
produce dsRNA by using a MEGAscript RNAi kit
(Ambion). A 15mg dsRNA was transfected into 2ml S2*
cells (1 10
6/ml in 6-well plate) using a calcium phosphate
precipitation method (see above) with or without reporter
plasmid.
Immunoprecipitation and complex analysis
S2* cells were seeded in 6-well plates and transiently
transfected with pAC-Tis11-His plasmid or blank
control pAc5.1-Flag-V5-His C vector using a calcium
phosphate precipitation method (see above). Three days
later, the S2* cells were stimulated with LPS for 3h,
inducing AMP mRNA to high levels. The cells were
then lysed for 10min on ice in RNA immunoprecipitation
(RIP) buﬀer [50mM Tris (pH 7.4), 150mM NaCl, 0.5%
Nonidet P-40, 1mM DTT, 100 U/ml RNase inhibitor
(Promega), 2.5% proteinase inhibitor cocktails (Sigma),
2mM vanadyl ribonucleoside complexes (NEB)]. The
cell lysate was centrifuged at 14000g for 10min at 4 C
and the supernatant of the cytoplasmic lysate was col-
lected for RNA IP assays. Precleared with protein-A
Sepharose beads (Amersham), lysates were incubated
with 1mg mouse His-tag antibody to immunoprecipitate
Tis11-His fusion protein and rotated for 12h at 4 C. Five
percent (v/v) protein-A beads were added for another 4h
and were washed several times with RIP buﬀer for IP
complex isolation. RNA was extracted from the IP
complex and the presence of speciﬁc mRNAs in the IP
complex was determined by RT–PCR with gene-speciﬁc
primers. A low-level signal of housekeeping transcript
rp49 was detectable in all samples and served to monitor
the quality and evenness of sample input.
RESULTS
Transiently expressed AMP genes have distinct kinetics
and show substantial diﬀerences in mRNA stability
Posttranscriptional regulatory studies of the expression of
genes encoding AMPs with distinct antimicrobial spectra
were performed on the widely used Drosophila cellular
model—macrophage-like S2 cells which can express a
spectrum of AMPs in response to immune stimulants
and can thus allow more precise manipulation.
To determine the similarity and dissimilarity in expres-
sion proﬁles of AMP genes, an absolute quantitative real-
time RT–PCR method was used to compare the mRNA
expression levels of diﬀerent AMPs. As shown in Figure
1A, whether or not S2* cells were stimulated with LPS for
2 and 4h, the mRNA of CecA1 was the most abundant
transcript among the detected AMPs including Dpt, Def,
Dro, AttB, Mtk and Drs. The mRNA levels of the other
AMPs were moderate, while Dpt mRNA displayed a rela-
tively high level. To investigate whether the gene expres-
sion of the CecA1 and other AMPs were diﬀerentially
regulated, we ﬁrst examined the expression kinetics of
CecA1 and Dpt by comparing their mRNA time course
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CecA1 and Dpt mRNA expression proﬁles from 0 to
10h in S2* cells stimulated with LPS. Both had similar
fold changes of mRNA levels when stimulated and
showed comparable transient expression characteristics.
However, it was observed that the CecA1 mRNA
decreased rapidly to almost basal level within 4–6h,
whereas the Dpt mRNA remained at a high level for up
to 10h. Obviously, the two AMP mRNAs had diﬀerent
expression kinetics as a result of diﬀerential regulation.
To determine whether mRNA stability was involved in
the diﬀerence between the two AMP expression proﬁles,
Act.D chase studies were used to eliminate eﬀects of tran-
scription on AMP expression and to determine the rate
of mRNA decay. As shown in Figure 1D, the decay rate of
CecA1 mRNA (t1/2=1.73h) was much quicker than that
of Dpt mRNA which remained stable (t1/2>4h) through-
out the course of the 4-h observation with LPS treatment
(Figure 1D). The results clearly show that CecA1 mRNA
is much more unstable than Dpt mRNA, indicating
that mRNA stability is an important determinant in the
diﬀerences in extent and duration of AMP gene expression
after immune stimulation.
To test whether the stability of AMP mRNA was
inﬂuenced by immune stimulation, CecA1 and Dpt
mRNA decay rates were also detected in S2* cells at
basal level without LPS treatment (Figure 1E). Never-
theless, the decay rate of CecA1 mRNA was almost the
same as the stimulated one with a half-life of 1.8h, while
Dpt mRNA was signiﬁcantly stable during the 4-h obser-
vation period. Thus, the mRNA stability of each AMP
was not altered whether or not S2* cells were stimulated
with LPS (Figure 1, compare D and E). These results
suggest that the decay rates of CecA1 and Dpt mRNAs
were well maintained in a constitutive manner and that the
mRNA stability of both AMPs were under posttran-
scriptional regulatory control which could sustain a
steady decay rate for the transcript in response to LPS
stimulation.
In contrast to Dpt 30-UTR, the CecA1 30-UTR is
suﬃcient to confer instability on a reporter mRNA
As for the posttranscriptional control of mRNA stability,
the AU-rich sequences can be found in the 30-UTR of
several AMP mRNAs. Both the CecA1 30-UTR and Dpt
30-UTR contain AU-rich sequences which may act as
Figure 1. The gene expression proﬁles and mRNA stability of diﬀerent AMPs. (A) Absolute quantitative real-time RT–PCR analysis of the amount of
AMPs and rp49 transcript in S2*cells treated with 10mg/ml LPS for 0, 2 and 4h, with the use of an ampliﬁcation standard curve for each gene. Taking
the amount of rp49 as 1, the expression level of each AMP was calculated. (B and C) The qRT–PCR analysis of CecA1 (B) and Dpt (C) mRNA in S2*
cells treated with 10mg/ml LPS for the time indicated. The fold changes of CecA1 and Dpt mRNA were detected at each time point, taking the mRNA
level at 0h as 1. (D and E) S2* cells were stimulated with LPS for 2h (D) or not stimulated (E), and further incubated with 10mg/ml Act.D for the time
indicated. The qRT–PCR was performed to detect CecA1 and Dpt mRNA remaining at each time point, taking the mRNA level at the time of Act.D
added as 1. Values represent the mean±SD (n=3 independent experiments), *P<0.05; **P<0.01 for CecA1 versus Dpt at each time point.
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Therefore, reporter gene constructs of the luciferase
reporter assay system were created by inserting DNA
encoding the 30-UTR of CecA1 or Dpt downstream of
the Fluc gene which was driven by actin5C promoter
(Figure 2A). To validate the reliability of this method,
we used the 30-UTR of rp49, a housekeeping gene, as a
stable control and HSP 70 30-UTR as an unstable control
(37) for the reporter system. Insertion of the HSP70
30-UTR resulted in great reduction of Fluc at protein
level and mRNA level with up to 80% expression
inhibited, whereas insertion of rp49 30-UTR had a little
but not signiﬁcant eﬀect on the expression as compared
with pAC-Fluc control vector without 30-UTR sequence
inserted (Figure 2B and C). Subsequently, the regulatory
roles of AMPs 30-UTR were analyzed using this eﬀective
and eﬃcient reporter system for posttranscriptional
studies.
Compared with the control in which no 30-UTR
was inserted, inserting the 30-UTR of CecA1 down-
stream of the Fluc resulted in a 60% decrease in Fluc
expression at both mRNA level and protein level
(Figure 2B and C). This indicated that CecA1 30-UTR
control of reporter expression mainly occurred at the
mRNA level and that the CecA1 30-UTR harbors a cis
element necessary to destabilize the reporter Fluc
mRNA. In contrast, inserting the Dpt 30-UTR increased
Fluc activity up to 70% but showed no signiﬁcant changes
at Fluc mRNA level, implying that a cis element
modulating translation eﬃciency could exists within the
Dpt 30-UTR.
To further examine whether the change of Fluc mRNA
level under the control of diﬀerent AMP 30-UTR might be
due to mRNA stability, Act.D chase studies were used. As
shown in Figure 2D, the Fluc mRNA decay rate observed
with CecA1 30-UTR (t1/2=0.63h) was faster than that
seen with Dpt 30-UTR (t1/2=1.5h) or with no insert
(t1/2=1.67h).
These results demonstrate that the 30-UTR of diﬀerent
AMPs contributes greatly to the mRNA stability which in
turn aﬀects gene expression diﬀerentially.
The ARE in the proximal region of CecA1 30-UTR is
the cis-acting element destabilizing mRNA
While the AU-rich sequence in Dpt mRNA 30-UTR has
been characterized for its binding ability with AUBP in
a previous study (38), the CecA1 mRNA 30-UTR con-
tains several AU-rich sequence motifs which are scattered
in the proximal region and the distal region. To clarify
the role of these AU-rich sequences and to localize the
cis element of CecA1 30-UTR contributing to down-
regulation of gene expression, a series of fragments of
CecA1 30-UTR was subcloned into the 30-end of the Fluc
coding sequence to generate various Fluc reporter
constructs (Figure 3A). In comparison with control
vector with no insert, fragments II and III both contain-
ing the AU-rich sequence in the proximal region decreased
Fluc mRNA level signiﬁcantly and resembled the inhi-
bition eﬀect of the full 30-UTR (fragment I) to a great
extent (Figure 3B). Fragment IV, containing the
AU-rich sequence in the distal region, only had a weak
eﬀect without signiﬁcance in reducing Fluc mRNA level.
Fragment V, the short proximal region excluding
AU-rich sequence, had no obvious eﬀect. Furthermore,
as shown in Figure 3C, the Fluc protein activity inﬂuenced
by diﬀerent fragments of CecA1 30-UTR was consis-
tent with its own mRNA level, demonstrating that the
suppression of Fluc activity is due to reduction at
the mRNA level. Overall, these results indicate that the
AU-rich sequence (nt 20 to 55) in the proximal region
is the AU-rich element (ARE) contributing to the
decreased reporter expression and that this CecA1 ARE
in 30-UTR can control its mRNA stability and regulate
CecA1 expression.
Figure 2. CecA1 and Dpt 30-UTR inﬂuenced reporter expression diﬀerently. (A) Diagram of reporter gene constructs pAC-Fluc-30-UTR. The
30-UTR of CecA1, Dpt, rp49 and HSP70 (sequences shown in Supplementary Table 4) were inserted downstream of the reporter Fluc gene
coding region which is indicated by the black bar. The 30-UTR is represented by the shaded bar of proportional length. Thin lines indicate the
AU-rich sequence sites in CecA1 and Dpt.( B) Fluc mRNA levels in S2* cells co-transfected with Fluc reporter plasmids containing the 30-UTR of
diﬀerent genes and Rluc reporter plasmid as normalization control. The qRT–PCR was performed to detect the transcript of Fluc. Fluc mRNA
measured in cells transfected with the pAC-Fluc control vector was designated as 1. Values represent the mean±SD of at least four experiments
(**P<0.01 for each construct versus pAC-Fluc). (C) Luciferase activity assays of S2* cells co-transfected with Fluc reporter plasmids containing the
30-UTR of diﬀerent genes and Rluc reporter plasmid used as normalization control. Fluc activity measured in cells transfected with the pAC-Fluc
control vector is designated as 1. Values represent the mean±SD of at least four experiments (**P<0.01 for each construct versus pAC-Fluc).
(D) S2* cells were transfected with Fluc reporter plasmids containing the 30-UTR of CecA1, Dpt or no 30-UTR inserted, and then incubated with
Act.D for the time indicated. The qRT–PCR was performed to detect Fluc mRNA remaining at each time point, taking the Fluc mRNA level of each
construct at the time of Act.D addition as 1. Values represent the mean±SD (n=3 independent experiments).
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regulating CecA1 expression through ARE in the 30-UTR
AREs exert their eﬀect on gene expression through inter-
action with speciﬁc ARE binding proteins (AUBPs) or
with the help of microRNA (miRNA) (20–23,26,39–41).
To identify genes that are required for CecA1 mRNA
instability control, a list of dsRNAs that target the
known AUBPs, including Tis11, ELAV, RBP9 and
small RNA processing factor Dicer1 were generated and
used in the AUBPs knockdown by RNA interference
(RNAi). These dsRNAs were co-transfected into S2*
cells with a reporter construct containing the indicated
30-UTR and Fluc activity changes were measured.
Compared with the Fluc control construct with no
30-UTR inserted, the treatments of dsRNA speciﬁc for
ELAV, RBP9 or Dicer1 had no obvious eﬀect on Fluc
activity for constructs inserted with diﬀerent 30-UTR
(data not shown). However, dsRNA-treatments targeting
Tis11 (Figure 4A), a homologue of mammalian TTP,
increased Fluc activity  50% for the reporter construct
inserted with CecA1 30-UTR (Figure 4B). This eﬀect
appeared speciﬁcally mediated by the 30-UTR of CecA1
since knocking down Tis11 by RNAi had no obvious
eﬀect on Fluc activity changes when the constructs were
inserted with rp49 30-UTR, Dpt 30-UTR or when no
30-UTR was inserted.
Taking advantage of the deletion mutants described in
Figure 3A, we next investigated which portion of the
CecA1 30-UTR is indispensable for the destabilization by
Tis11. Reducing Tis11 expression through RNAi can
increase the Fluc activity  50% when fragment II or
fragment III containing the ARE of CecA1 30-UTR is
inserted. Conversely, Tis11 RNAi had no signiﬁcant
eﬀect when the constructs were inserted with fragment
IV or V of CecA1 30-UTR (Figure 4B). These results
show that Tis11 speciﬁcally downregulates CecA1 gene
expression through the ARE deﬁned in the proximal
region of 30-UTR for mRNA stability control.
To determine whether mammalian TTP can regulate
AMP expression, a TTP expression construct was
co-transfected into S2* cells with dsRNA targeting Tis11
such that Tis11 was knocked down by RNAi. The expres-
sion of mammalian TTP decreased the Fluc activity
signiﬁcantly in S2* cells transfected with reporter con-
struct inserted with CecA1 30-UTR and rescued the
destabilizing eﬀect on reporter mRNAs bearing AREs
from mammalian (TNF- ) and Drosophila sources
(CecA1) in S2* cells where Tis11 were knocked down by
RNAi (Figure 4C). No signiﬁcant destabilizing eﬀects of
TTP on reporter mRNA bearing Dpt 30-UTR were
observed in S2* cells with or without Tis11 knockdown.
It appears that the mammalian and Drosophila TTP
orthologs share functional similarity regarding the
speciﬁc regulation of mRNA with CecA1 30-UTR but
not Dpt 30-UTR.
Tis11 selectively destabilizes CecA1 mRNA and inﬂuences
the transient expression kinetics
To determine whether Tis11 can diﬀerentially reduce the
endogenous AMP mRNA stability, Act.D chase studies
were performed after S2* cells were treated with dsRNA
of Tis11 or EGFP (negative control) for 3 days and
stimulated with LPS for 2h. As shown in Figure 5A, the
stability of CecA1 mRNA was signiﬁcantly increased
when Tis11 was knocked down (t1/2=2.02h versus
t1/2=4.35h). Conversely, knocking down Tis11 did not
change the Dpt mRNA stability (Figure 5B). To further
validate the eﬀectiveness of Tis11-regulated mRNA stabil-
ity on the AMP mRNA expression kinetics, CecA1 and
Dpt mRNA expression proﬁles in S2* cells, in which Tis11
was knocked down by RNAi, were detected after LPS
stimulation. As shown in Figure 5C, CecA1 mRNA had
a similar fold increase, but remained at a high level longer
in Tis11 knocked down cells. The expression proﬁles of
Dpt mRNA were similar whether Tis11 was knocked
down or not (Figure 5D).
These data demonstrate that Tis11 can speciﬁcally
destabilize CecA1 mRNA and can quickly eliminate
CecA1 mRNA to manipulate the transient expression
proﬁles of the potent AMPs when rapidly induced.
Figure 3. Eﬀects of CecA1 30-UTR fragments on reporter expression. (A) The sequence of CecA1 30-UTR and schematic of the diﬀerent fragments
inserted downstream of the Fluc. AUUUA pentamer or AUUUUA hexamer are underlined. Each rectangle indicates an AU-rich sequence site.
The AU-rich sequence with U surrounding it is indicated as a black rectangle. (B) Fluc mRNA levels in S2* cells which were co-transfected with Fluc
reporter plasmids containing the diﬀerent fragments of CecA1 30-UTR and Rluc reporter plasmid as normalization control. The qRT–PCR was
performed to detect the expression level of Fluc mRNA. Fluc mRNA measured in cells transfected with the pAC-Fluc control vector is designated as
1. Values represent the mean±SD of at least four experiments (**P<0.01 for each construct versus pAC-Fluc). (C) Luciferase activity assays of S2*
cells co-transfected with Fluc reporter plasmids that were inserted with diﬀerent fragments of CecA1 30-UTR and Rluc reporter plasmid used as
normalization control. Fluc activity measured in cells transfected with the pAC-Fluc control vector is designated as 1. Values represent the
mean±SD of at least four experiments (**P<0.01 for each construct versus pAC-Fluc).
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stability and expression proﬁles of moderately expressed
Dpt.
CecA1 mRNA forms an RNA–protein complex with
Tis11 in S2* cells
To investigate the activity of Tis11 in speciﬁc and direct
interaction with AMP mRNA in S2* cells, an IP RT–PCR
method was used to measure the amount of mRNA that
coprecipitated with Tis11 protein. As shown in Figure 6A,
IP with anti-His antibodies dramatically enriched CecA1
mRNA in RNP complexes from cells transfected with the
construct expressing the Tis11–His fusion protein,
whereas, IP in cells transfected with the construct contain-
ing the His tag control had no such eﬀect. In contrast, IP
resulted in no enrichment for other mRNAs tested
including Dpt (Figure 6A), Def, Dro, AttB, Mtk and Drs
in S2* cells expressing blank His tag or Tis11–His fusion
protein (data not shown).
The changes in CecA1 mRNA after IP were also
analyzed using qRT–PCR. After IP with anti-His
antibodies in extracts from cells expressing Tis11–His
fusion protein, the endogenous CecA1 mRNA was dra-
matically enriched up to 14-fold as compared with rp49
(Figure 6B). In contrast, none of the other AMP mRNA
tested, including Dpt (Figure 6B), Def, Dro, AttB, Mtk
and Drs, was enriched (data not shown).
These data demonstrate that Tis11 speciﬁcally forms
an RNP complex with CecA1 mRNA, but not with Dpt
mRNA or any other AMP mRNA examined here in S2*
cells. These ﬁndings provide strong evidence that the
speciﬁc interaction between Tis11 and CecA1 mRNA is
the essential molecular basis for the diﬀerential regulation
of genes with distinct expression kinetics.
A crucial role for p38MAPK in diﬀerential regulation
of AMP mRNA stability mediated by Tis11
In order to examine the role of p38MAPK in regulating
the stability of AMP mRNAs bearing AREs, we
investigated the eﬀect of p38MAPK blockade on LPS-
induced posttranscriptional regulation of AMP expres-
sion. As shown in Figure 7A, inhibition of p38MAPK
employing a speciﬁc inhibitor, SB203580, decreased the
half-life of CecA1 mRNA signiﬁcantly, whereas Dpt
mRNA remained stable and its half-life was unchanged
(Figure 7B). These observations demonstrate that LPS-
activated p38MAPK stabilizes mRNAs bearing the
AREs in S2* cells and that there exist diﬀerences in the
extent and duration of p38MAPK inhibition between
CecA1 and Dpt ARE.
Through detection of Tis11 expression at mRNA level,
it was indicated that LPS stimulation and/or p38MAPK
blockade aﬀect the Tis11 expression to some extent
but not signiﬁcantly (Figures 7C). To determine the
involvement of Tis11 in p38MAPK-regulated mRNA sta-
bilization, the eﬀects of a p38MAPK blockade on CecA1
mRNA stability were tested in S2* cells with Tis11
knocked down by RNA interference. As shown in
Figure 7D, inhibitor SB203580 treatment blocked the sta-
bilization eﬀect of p38MAPK and destabilized CecA1
mRNA to a shorter half-life as compared with the
DMSO treated control. However, pretreatment with
RNAi knockdown of Tis11 abrogated the destabilization
eﬀect of p38MAPK inhibition by SB203580 and increased
the half-life of CecA1 mRNA to an extent comparable to
the half-life upon Tis11-knockdown-induced stabilization.
These results demonstrate that the stabilization eﬀect of
LPS-activated p38MAPK on CecA1 mRNA is mediated
by the RNA destabilizing protein Tis11 in Drosophila.
Figure 4. Knocking down Tis11 increased the activity of the reporter construct containing CecA1 30-UTR. (A) RT–PCR was performed using
speciﬁc primers to conﬁrm the knockdown eﬃciency of Tis11 in S2* cells treated with EGFP or Tis11 dsRNA. Results shown are representative of
three independent experiments. (B) Fluc activity changes after Tis11 RNAi. S2* cells were co-transfected with dsRNA speciﬁc for Tis11 or EGFP
and a reporter construct inserted with diﬀerent 30-UTR. Luciferase activity was assayed as described. Compared in cells transfected with EGFP
dsRNA (mock RNAi), the Fluc activity changes in Tis11 knocked down cells is shown. Values represent the mean±SD of at least four experiments
(*P<0.05; **P<0.01 for each construct versus both pAC-Fluc and pAC-Fluc-rp49). (C) S2* cells were co-transfected with dsRNA targeting Tis11
or EGFP, human TTP expression plasmid (pAC-TTP-Flag) or control plasmid (pAC- Flag) and a reporter construct inserted with diﬀerent 30-UTR.
Luciferase activity was assayed as described. Fluc activity measured in cells co-transfected with the pAC-Fluc control vector, EGFP dsRNA and
pAC-Flag control expression plasmid is designated as 1. Values represent the mean±SD of at least three experiments (*P<0.05; **P<0.01 for each
construct versus pAC-Flag control plasmid).
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Drosophila melanogaster can produce a large variety of
AMPs, especially when a pathogen entering the body
triggers the innate immune system, as shown in previous
reports with Northern or micro array analyses using whole
ﬂies (10,12,15). Each AMP has a diﬀerent antimicrobial
spectrum and works together with others against micro-
bial infection (1–3). On the other hand, AMPs have great
inﬂuence on the resident microbiota community which
is important for sustaining host health and must be main-
tained properly (8,9). The overall eﬀects of AMPs on
pathogenic and commensal microbes are attributed to
each individual AMP with its distinct antimicrobial
spectrum. Undoubtedly, a controllable and dynamic
antimicrobial spectrum of an integrated variety of AMPs
is a complex event and is dependent upon eﬀectively
and diﬀerentially regulated expression of each AMP
gene displaying distinct expression kinetics upon immune
response.
In accordance with previous reports (12,18), we observe
that, in S2* cells, the AMP genes were transiently
expressed in a characteristic pattern in which the mRNA
level increased quickly to its peak and declined afterwards
upon immune response (Figure 1 and data not shown).
Notably, CecA1 mRNA had the highest peak level and
the quickest declining rate among all the AMPs tested,
including the moderately expressed Dpt, Def, Dro, AttB,
Mtk and Drs. The diﬀerences in intensity and duration of
gene expression indicate that the AMP genes were not
regulated through the same mechanism although they
shared a similar transient expression pattern. Comparing
various properties of AMPs, we noted that the property
distinguishing CecA1 from the other AMPs was its broad
spectrum of antimicrobial activity. Previous studies
have shown that CecA1 has a broad antimicrobial
spectrum against Gram-positive bacteria, Gram-negative
bacteria and fungi, while the antimicrobial spectra of
other AMPs are quite limited. For example, the Dpt
only impacts anti Gram-negative bacteria (1–3,6,7).
Therefore, modulating CecA1 expression could have sig-
niﬁcant impact on the overall antimicrobial spectrum
produced by all the AMPs. According to this perspective,
diﬀerential regulation of genes encoding a functionally
distinctive AMP, such as CecA1, is crucial for the host
Figure 5. The changes in mRNA stability and gene expression proﬁles of AMPs after Tis11 knockdown. (A and B) S2* cells were transfected with
dsRNA speciﬁc for Tis11 or EGFP and cultured for 72h. After exposure of cells to LPS for 2h, Act.D was added and the preparation incubated for
the indicated times. The qRT–PCR was performed to detect CecA1 (A) and Dpt (B) mRNA remaining at each time point, taking the expression level
at the time of Act.D addition as 1. (**P<0.01 for EGFP dsRNA versus Tis11 dsRNA at each time point) (C and D) The qRT–PCR analysis of
CecA1 (C) or Dpt (D) transcripts in S2* cells after LPS treatment under EGFP or Tis11 RNAi conditions. The fold change of CecA1 or Dpt mRNA
was analyzed, taking the expression level in cells transfected with EGFP dsRNA at time point of 0h as 1. The data presented are mean±SD of four
independent experiments.
Figure 6. The mRNA analyses of RNP complex IP with Tis11. S2* cells were transfected with construct expressing Tis11-His tag or His tag and
incubated for 72h. Cells were stimulated with LPS for 3h and then lysed to IP with anti-His tag antibody. (A) RNAs in the cell lysate and the IP
complex were identiﬁed using RT–PCR with primers speciﬁc for CecA1, Dpt or rp49. Results shown are representative of three independent
experiments. (B) The CecA1 and Dpt mRNA in the IP complex were analysed by qRT–PCR to evaluate the relative enrichment after co-IP,
taking the ratio of rp49 mRNA level in IP samples to cell lysate as 1. Values represent the mean±SD of three independent experiments
(**P<0.01 for cells expressing Tis-His versus His-tag control).
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spectrum using a combination of individual AMPs.
Since gene regulation depends upon the interplay
among elements that control gene expression at multiple
levels including transcription, mRNA stability and trans-
lation, the diﬀerences in intensity and time of sustained
high level between CecA1 and the other AMPs may be
attributed to diﬀerential regulation at multiple levels.
Previous studies have shown that the diﬀerences in the
kB motif at the promoters of CecA1 and Dpt are not func-
tionally equal, a fact that can partly explain the diﬀerent
expression proﬁles (16–18). However, neither expression
proﬁles nor elimination of existing mRNA can be
exclusively governed by transcriptional control. In fact,
here we show that CecA1 mRNA is much more unstable
than Dpt as demonstrated using Act.D chase studies for
mRNA half-life measurement. These experiments partly
explain why CecA1 is eliminated more quickly in LPS-
elicited transient expression. In addition, the mRNA
decay rate of each AMP was not altered whether or not
S2* cells were stimulated with LPS. This was conﬁrmed by
additional experiments with reporter constructs contain-
ing Dpt or CecA1 30-UTR, in which the Fluc activity was
regulated by the inserted 30-UTR but not aﬀected by LPS
treatment (data not shown). These results indicate that
the decay rates of CecA1 and Dpt mRNAs are main-
tained in a constitutive manner and that the sustained
pattern of mRNA stability of both AMPs is under post-
transcriptional regulatory control upon LPS stimulation.
The steady decay rate of unstable mRNA results in
the eﬀective and constant elimination of mRNA. The
expression of low stability genes means quick synthesis
and quick mRNA decay and consumes more energy,
which is also important for the host. However,
compared with induction-dependent regulation, constitu-
tive instability of mRNA is an extremely fast and eﬀective
mode for negative control of transient gene expression
upon immune response. Of note, proper down-modula-
tion of immunity is critical for protective immunity and
health (8,9,42–44), and recent work has shown that
hyperactivated or prolonged immune responses, including
the expression of AMPs, are detrimental to the host,
partly because of an altered commensal microbe popula-
tion (8,9). A series of negative regulators that control the
intensity and duration of AMP expression, mainly at the
transcriptional level, have been identiﬁed. In extracellular
compartments, hemocytes phagocytose microbes and
some secreted PGRPs for enzymatic degradation of
peptidoglycan (45,46). Inside a host cell, Drosophila Wnt
inhibitor of Dorsal (wnt D), Defense repressor 1 (Dnr1),
caspar, PIMS and rudra/pirk downregulate the Toll
or IMD pathways, the major regulators of the immune
response in cytoplasm of Drosophila (43,44,47–50). In
the nucleus, AP-1 and STAT complex, activated by the
JNK pathway, inhibit AMP expression through
removing Relish from the promoter (51). In addition to
those transcriptional down-modulations, posttrans-
criptional events, particularly the instability of speciﬁc
mRNAs reported here, are also important determinants
of the downregulation of AMP gene expression. Given
that CecA1 has a more potent response and a broader
spectrum of antimicrobial activity than do the other
AMPs, diﬀerential instability control may play an impor-
tant role in the strict regulation of its gene expression
to avoid excessive eﬀects harmful to resident microbiota
and deleterious to host health. Conversely, the moderately
expressed Dpt with activity against Gram-negative
bacteria may have a less deleterious eﬀect upon the host.
Hence, it may not be necessary to eliminate Dpt mRNA
quickly with an mRNA instability mechanism. The diﬀer-
ence in mRNA stability between AMPs with diﬀerent
antimicrobial spectra provides an eﬀective approach for
exact control of AMP gene expression contributing to
the integrated antimicrobial activity.
In the 30-UTR of a variety of transiently expressed
immediate response genes there is an ARE involved in
the posttranscriptional regulation (20–23,25,26). It is
highly conserved throughout evolution and can be found
in species ranging from yeast and insects to mammals.
Both CecA1 and Dpt contain AU-rich sequences in the
30-UTR, which likely serve as cis-acting elements and
may be involved in posttranscriptional regulation.
Figure 7. Eﬀect of p38MAPK inhibition by SB203580 on AMP mRNA stability and Tis11 expression. SB203580 or vehicle (1% DMSO) pretreated
S2* cells were incubated with 10mg/ml LPS for 2h. Act.D chase studies were performed to detect CecA1 (A) and Dpt (B) mRNA remaining at each
time point, taking the expression level at the time of Act.D addition as 1. (C) S2* cells were pretreated for 0.5h with SB203580 or vehicle. Afterward,
cells were incubated with LPS for diﬀerent times. The fold changes of Tis11 mRNA were detected at each time point, taking the mRNA level of
vehicle at 0h as 1. (D) S2* cells were transfected with dsRNA speciﬁc for Tis11 or EGFP and cultured for 72h. The cells were then treated as
described in (A). qRT–PCR was performed to detect CecA1 mRNA remaining at each time point, taking the expression level at the time of Act.D
addition as 1.
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the ARE in the proximal region, can eﬀectively accelerate
reporter mRNA decay and decrease reporter mRNA level
as well as reporter Fluc activity. In most cases, the mag-
nitude of the decrease in Fluc activity was directly
correlated with the corresponding decrease in Fluc
mRNA level, suggesting that reporter gene expression
is primarily dependent upon message stability. These
results are consistent with the instability of the CecA1
mRNA and indicate that CecA1 30-UTR contains a func-
tional ARE, a cis element destabilizing mRNA. However,
inserting Dpt 30-UTR downstream of the reporter has no
obvious eﬀect on reporter mRNA stability change, but
increases the reporter Fluc activity signiﬁcantly. This
implies that a cis element increasing the translation eﬃ-
ciency may exist within the Dpt 30-UTR or that additional
trans factors may be involved in the modulation of
translational eﬃciency, all of which possibilities should
be further investigated. The diﬀerent roles of CecA1 and
Dpt 30-UTR on mRNA stability and protein expression
indicate that 30-UTR plays important roles in versatile and
diﬀerential regulation of AMP gene expression.
AREs function as posttranscriptional regulatory
elements through interactions with speciﬁc binding
proteins or microRNA (20,21,26,39). Using RNA interfer-
ence to screen known RNA binding proteins, we identiﬁed
Drosophila Tis11, a homolog of mammalian TTP,
as a trans-factor controlling CecA1 mRNA stability.
Characterized by a tandem CCCH zinc-ﬁnger (TZF)
domain with highly conserved sequences and spacing,
TTP can bind to ARE of unstable mRNAs through
TZF domains and can induce mRNA deadenylation, pro-
mote degradation of the mRNA body by the exosome
complex, or assist the RISC–miRNA complex with target-
ing mRNA for rapid degradation (39,52–54). Drosophila
Tis11 also contains two CCCH zinc-ﬁnger domains
that are necessary for mammalian TTP to interact with
AU-rich elements, destabilizing the mRNA of reporter
construct with CecA1 30-UTR mainly through interaction
with the ARE in the proximal region of CecA1 30-UTR.
Moreover, we demonstrated, using an IP RT–PCR
method, that CecA1 mRNA and Tis11 were
co-precipitated in an RNA–protein complex. It is
observed that the ARE in the proximal region of CecA1
30-UTR contains a UUAUUUAUU sequence,
characterized previously as a preferred binding site for
mammalian TTP, and indicates that Drosophila Tis11
has a similar binding characteristic to that of mammalian
TTP. Although Dpt mRNA 30-UTR contains the AU-rich
sequence, UAUUUUAUU, which also has an optimal
aﬃnity to mammalian TTP (32,33), it can increase Fluc
reporter activity but cannot be pulled down with
Drosophila Tis11 protein using co-IP. This is consistent
with the fact that knocking down Tis11 or over-expressing
TTP has little eﬀect on Dpt mRNA stability and expres-
sion proﬁles. Perhaps Dpt does not have the same recog-
nition and binding property as mammalian ARE, or
additional factors involved in inﬂuencing the aﬃnity
and speciﬁcity of the RNA–protein complex forming
with Tis11.
Data from the work of Jing et al. (39) have shown that
the Drosophila Tis11 can destabilize reporter mRNA
inserted with TNF-  30-UTR and the involvement of
microRNA is indicated. However, reducing the expression
of Dicer1, playing key roles in processing small RNAs in
miRNA systems, has no eﬀect on expression of reporters
inserted with CecA1 30-UTR (data not shown) indicating
that a RISC–miRNA complex does not participate in
CecA1 mRNA stability control. While preparing this
article, we noticed that recent work reported by Aure ´ lien
et al. (55) demonstrated that Tis11 downregulates
CecA1 mRNA stability through acceleration of mRNA
deadenylation similar to that of TTP in mammals.
AREs can exert mRNA instability eﬀects but can also
confer stabilization of mRNA through the p38MAPK
pathway. p38MAPK has been shown to regulate both
the translation and the stability of inﬂammatory
mRNAs bearing AREs, including TNF- , COX-2,
GMCSF and VEGF (30,31), in mammalian cells.
Previous study has shown that p38MAPK regulates
levels of AMP transcripts in Drosophila (56). We have
demonstrated in this study that p38MAPK plays a
crucial role in regulating the stability of AMP mRNAs
bearing the AREs in their 30-UTR upon LPS activation
of p38MAPK in S2* cells. The p38MAPK inhibitor
SB203580 can speciﬁcally and eﬀectively decrease the
half-life of CecA1 mRNA. Of note, our results in this
report indicate that the decay rate of CecA1 mRNA
remains unaﬀected upon LPS stimulation as compared
to the basal level. Thus, it is suggested that p38MAPK
contributes its stabilizing role to a regulatory mechanism
coordinating stabilizing and destabilizing regulation to
ensure a steady level of degradation rate of the transcript
upon LPS stimulation.
The important component of the mechanism of
p38MAPK-regulated mRNA stability is a protein that
forms the link between the p38MAPK pathway and
ARE-containing mRNA. In mammals, the TTP has
been suggested to be the protein factor but is not ﬁrmly
recognized because of evidence for and against its involve-
ment in p38MAPK-mediated stabilization (30,57). Using
RNAi knockdown of Tis11, the Drosophila homolog of
TTP, we observed that the destabilizing eﬀect of
p38MAPK blockade by SB203580 was abrogated. This
provides evidence that Tis11 is involved in the regulation
of AMP mRNA stability by p38MAPK in S2* cells.
Further detection of Tis11 expression at mRNA level
indicates that LPS stimulation and/or p38MAPK
blockade aﬀects Tis11 expression to some extent but not
signiﬁcantly. It remains unclear as to how p38MAPK
regulates AMP mRNA stability mediated by Tis11-
AREs interaction. In the future, it would be of interest
to determine whether protein phosphorylation of Tis11
aﬀects the regulation of mRNA stability and whether
p38MAPK regulates the phosphorylation status of Tis11.
ARE is a highly conserved posttranscriptional regula-
tory element throughout evolution and can be found in
species from yeasts and insects to mammals (24–26). Our
previous study (38) has shown the existence of ARE in
30-UTR of AMP mRNA. We further demonstrate in this
report that AREs in 30-UTR of AMP mRNA are
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of AMP gene expression, a mechanism that is extremely
important in the innate immunity of insects. Likewise,
AREs have been known to play critical roles in the post-
transcriptional regulation of gene expression in response
to immune stimuli in mammals. It was emphasized and
explicated in a recent study that ARE-regulated mRNA
stability exerts a strong inﬂuence on gene expression, in
some cases overriding that of transcriptional control
elements, and controlling the expression kinetics of genes
encoding inﬂammatory molecules (58). In addition, the
trans-acting protein factor mediating ARE destabilization
is Drosophila Tis11, the ortholog of mammalian TTP.
Although the AREs of AMP mRNA exert no destabili-
zing eﬀect in mammalian cells (data not shown), our
results support a previous report (39) that the
Drosophila Tis11 can destabilize reporter mRNA
inserted with TNF-  30-UTR. Besides, expression of TTP
in S2* cells with Tis11 knockdown can rescue the
destabilizing eﬀect on reporter mRNAs bearing AREs.
This evidence indicates that the ARE destabilizing
trans-acting factors are evolutionarily conserved between
invertebrate and mammalian immune systems. Further-
more, we reveal that p38MAPK regulates the stability of
the AMP mRNA containing ARE in the 30-UTR as
mediated by Tis11, demonstrating a mechanism strikingly
similar to that of p38MAPK-regulated mRNA stabiliza-
tion in mammalian cells through inhibition of TTP-
mediated destabilization in most case (31). Obviously,
AREs and relevant regulatory mechanisms have become
more complex later in evolution, but the main framework
is evolutionarily conserved between invertebrates and
mammals and reﬂects many important mechanisms
present in ancestral forms. In particular, evolutionary con-
servation is manifested in posttranscriptional regulation of
gene expression in both ﬂy and mammalian immunity.
Taken together, our results demonstrate that AMPs
possessing diﬀerent antimicrobial spectra exhibit signiﬁ-
cant diﬀerences in gene expression proﬁles evidently
attributed to diﬀerential regulation at the posttrans-
criptional level. While Dpt 30-UTR has no destabilizing
eﬀect, CecA1 30-UTR is both necessary and suﬃcient to
confer instability through the ARE–Tis11 interaction
within the RNP complex. It is further demonstrated
that the destabilization is counteracted by p38MAPK
which plays a crucial role in stabilizing ARE-bearing
mRNAs by inhibiting Tis11-mediated degradation, a
posttranscriptional mechanism that is evolutionarily
conserved in both ﬂy and mammalian immunity.
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